As you read this, millions of people around the world are making antibodies against SARS-CoV-2. None of those people were born with a gene for those specific antibodies. Yet in just a couple of weeks following exposure to the virus–or now, one of its proteins via a vaccine–their immune systems can make antibodies that bind tightly and very specifically to the outside of the coronavirus, inhibiting its ability to infect their cells.